Significant AUC values of IGFBP2 were observed in gastric cancer, cholangiocarcinoma, hepatocellular carcinoma, colon cancer and duodenal cancer (Table 7) against healthy controls. This evidence concerns the gene IGFBP2 and malignant colon neoplasm.